secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2023-05-31T23:59:59+00:00
Accession:  0001493152-23-019652
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell to spin out pre-clinical assets into BriaPro; shareholders get 1 SpinCo share per each held
--------------------------------------------------------------------------------

- SpinCo to acquire Bria-TILsRx™ and PKCδ inhibitors from BriaCell.
- Each BriaCell shareholder receives 1 SpinCo share and 1 new BriaCell share; warrants adjusted similarly.
- Shareholders will own 33.33% of SpinCo; BriaCell retains 66.67%.
- Special shareholder meeting scheduled for July 2023; closing targeted by August 2023.
- Conditions: shareholder vote, court orders, TSX and Nasdaq approvals; board unanimously supports.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223019652/0001493152-23-019652-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223019652/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-019652

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer